Swiss National Bank - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 216 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$11,869,000
+56.6%
127,705
+0.3%
0.01%
+40.0%
Q3 2021$7,581,000
-12.0%
127,305
+0.8%
0.01%0.0%
Q2 2021$8,614,000
-6.6%
126,305
-5.0%
0.01%
-16.7%
Q1 2021$9,222,000
-7.9%
132,905
+2.0%
0.01%
-14.3%
Q4 2020$10,011,000
+6.2%
130,305
+3.4%
0.01%0.0%
Q3 2020$9,424,000
+20.6%
126,005
+1.5%
0.01%0.0%
Q2 2020$7,812,000
+91.3%
124,105
+27.6%
0.01%
+75.0%
Q1 2020$4,084,000
-5.7%
97,230
+2.0%
0.00%0.0%
Q4 2019$4,330,000
+1.4%
95,330
+2.1%
0.00%
-20.0%
Q3 2019$4,272,000
-20.7%
93,330
+1.5%
0.01%
-16.7%
Q2 2019$5,390,000
+33.5%
91,930
+2.1%
0.01%
+50.0%
Q1 2019$4,036,000
+18.8%
90,030
+3.2%
0.00%0.0%
Q4 2018$3,398,000
-14.0%
87,230
+1.6%
0.00%0.0%
Q3 2018$3,950,000
+8.3%
85,830
+2.6%
0.00%0.0%
Q2 2018$3,646,000
+10.4%
83,6300.0%0.00%0.0%
Q1 2018$3,303,000
+45.7%
83,630
+25.3%
0.00%
+100.0%
Q4 2017$2,267,000
+39.7%
66,730
+4.9%
0.00%0.0%
Q3 2017$1,623,000
+97.0%
63,630
+30.3%
0.00%
+100.0%
Q2 2017$824,00048,8300.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 505,670$34,487,0007.23%
Asymmetry Capital Management, L.P. 142,246$9,701,0006.67%
Prosight Management, LP 137,000$9,343,0005.84%
Avoro Capital Advisors LLC 4,075,000$277,915,0004.84%
Integral Health Asset Management, LLC 225,000$15,345,0004.22%
First Light Asset Management, LLC 617,124$42,088,0002.52%
SECTORAL ASSET MANAGEMENT INC 322,599$22,001,0001.78%
Avidity Partners Management LP 943,000$64,313,0001.74%
DAFNA Capital Management LLC 119,615$8,158,0001.71%
Nicholas Investment Partners, LP 298,247$20,340,0001.28%
View complete list of ARENA PHARMACEUTICALS INC shareholders